在患有多发性硬化症的女性中,治疗对类固醇的影响
Martin Hill1, Radmila Kancheva1, Marta Velíková1
1Institute of Endocrinology, 110 00 Prague, Czech Republic.
International journal of molecular sciences
|March 13, 2025
概括
多发性硬化症 (MS) 药物治疗改变女性的类固醇特征. 这些变化会影响激素产生和酶活性,可能会影响疾病严重程度和治疗优化.
科学领域:
- 神经内分泌学神经内分泌学
- 药理学 药理学是指药理学的学科.
- 代谢学 代谢学 代谢学
背景情况:
- 多发性硬化症 (MS) 是一种慢性神经炎症和神经退行性疾病.
- 类固醇激素的波动与MS有关,特别是在月经周期和怀孕期间.
- 关于MS的疾病修饰疗法如何影响类固醇组的数据有限.
研究的目的:
- 调查各种抗MS药物对MS妇女类固醇配置文件的影响.
- 分析类固醇水平的变化和反映酶活性的类固醇摩尔比率 (SMR).
- 探索这些类固醇变化与MS治疗疗效之间的潜在相关性.
主要方法:
- 使用GC-MS/MS和61名女性MS患者的免疫试验对79种类固醇的类固醇组分析.
- 评估类固醇水平和SMR以推断类固醇生成酶活性.
- 统计分析包括重复测量ANOVA,多重比较和OPLS模型.
主要成果:
- 抗MS治疗,特别是抗CD20单克隆抗体 (mAb),S1P受体抑制剂 (S1PRI) 和IFNβ-1a,降低了17-基怀孕和转移了CYP17A1活性.
- 随着格拉提拉默酸和抗CD20 mAb治疗,观察到合/非合类固醇比率的降低.
- IFN-β1a和ocrelizumab调节了像AKR1D1这样的酶,而S1PRI影响了SRD5A的活性;抗CD20 mAb减少了免疫调节性雄激素的合成.
结论:
- 抗MS疗法显著改变MS妇女的类固醇组.
- 这些变化涉及类固醇水平的变化,酶活性和生物活性类固醇的合成.
- 了解这些类固醇转移可能有助于优化多发性硬化症治疗策略和控制疾病进展.
更多相关视频
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
12.1K
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
12.1K
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
126
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
126
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
92
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
92